IHP 310 Module 6 Infection and Antimicrobial Case Analysis example

Reviewed by Delia Ravenscroft, MSN, RN Pathophysiology and Pharmacology Concepts Southern New Hampshire University Full sample paper Free custom sample in 24 to 48h

This complete IHP 310 Module 6 case analysis follows one antibiotic decision from start to finish. A composite 81-year-old nursing home resident with dementia has cloudy, strong-smelling urine but no fever or urinary symptoms. A culture grows E. coli, she receives ciprofloxacin, and ten days later she develops Clostridioides difficile infection. The paper explains colonization versus infection, how the antibiotic works and how it disrupts the gut, what national guidelines say, and how stewardship could have prevented the harm. The resident is invented; the guidelines are real.

What this page holds

An IHP 310 Module 6 case analysis, written out in full, of asymptomatic bacteriuria treated with ciprofloxacin and followed by C. difficile infection, with immune pathophysiology, drug mechanisms, a guideline review table, stewardship steps and references. Searches like "ihp 310 module 6 assignment", "ihp310 module 6 infection and antimicrobial case analysis" and "ihp 310 module 6 example" land here.

The IHP 310 Module 6 example, in full

1

Treating the Culture, Not the Patient: Asymptomatic Bacteriuria, Ciprofloxacin and C. difficile in an 81-Year-Old Nursing Home Resident

[Student Name]

Southern New Hampshire University

IHP 310: Pathophysiology and Pharmacology Concepts

Module Six Case Analysis

[Instructor Name]

[Date]

The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.

What this page is doingThe main title names the error in five words, and the subtitle lists the three links in the chain and the resident. A reader expects an analysis of how a lab result, rather than symptoms, drove treatment.
2

Treating the Culture, Not the Patient: Asymptomatic Bacteriuria, Ciprofloxacin and C. difficile in an 81-Year-Old Nursing Home Resident

The Case

Mrs. Bianchi is a composite 81-year-old nursing home resident with moderate Alzheimer disease, type 2 diabetes and urinary incontinence. A nursing assistant noticed that her urine looked cloudy and smelled strong, and the nurse obtained a urine culture. She had no fever, no new confusion beyond her baseline, no pain on urination and no change in vital signs. The culture grew more than 100,000 colonies of E. coli per milliliter. The on-call clinician prescribed ciprofloxacin 500 mg twice daily for seven days. Ten days after finishing it, she developed six watery stools a day, abdominal cramping and a white blood cell count of 14,000. A stool test was positive for toxigenic Clostridioides difficile.

Colonization Versus Infection

Infection means that microbes invade tissue and provoke an immune response that causes symptoms and signs: in the bladder, inflammation of the lining causes painful, frequent urination, and in the kidney, fever and flank pain. Colonization means that bacteria live in a body site without invading tissue or causing a harmful response. Bacteria in the urine without symptoms, called asymptomatic bacteriuria, is a form of colonization and is present in a large share of older nursing home residents, particularly women and those with incontinence.

Cloudy or strong-smelling urine reflects concentration, diet or the presence of bacteria and cells, not infection. National guidelines recommend against screening for or treating asymptomatic bacteriuria in older adults in long-term care, and against treating it in older adults with nonspecific changes such as confusion or falls when there are no urinary symptoms or signs of systemic infection (Nicolle et al., 2019). The culture in this case was never the problem; ordering it without symptoms set the chain in motion.

What this page is doingThe section defines colonization and infection in terms of the immune response and uses a named guideline to identify where the error occurred. The highlighted sentence locates the decision point precisely.
3

How Ciprofloxacin Works and What It Disrupted

Ciprofloxacin is a fluoroquinolone. It inhibits bacterial DNA gyrase and topoisomerase IV, enzymes that bacteria need to copy and separate their DNA, which kills the bacteria. It reaches high levels in urine, which is why it is often chosen for urinary infections. But it also has broad activity against bacteria in the gut and is associated with the emergence of resistant organisms.

The colon normally contains a dense community of bacteria that resists overgrowth by C. difficile through competition for nutrients and by altering bile acids that the organism needs to germinate. Antibiotics disrupt this community. Ingested C. difficile spores, common in health care facilities, can then germinate and produce toxins A and B, which damage the lining of the colon and cause diarrhea and inflammation. Advanced age, residence in a health care facility and antibiotic exposure are among the strongest risk factors for C. difficile infection (McDonald et al., 2018), and Mrs. Bianchi had all three. Fluoroquinolones have also been linked to spread of particularly virulent C. difficile strains, which adds to the case against using them when they are not needed.

Step-by-Step Review Against the Guidelines

The table compares each decision with guideline recommendations.

Table 1

Decisions in Mrs. Bianchi's Care Compared With Guidelines

StepWhat happenedGuideline-concordant alternative
Trigger for testingCloudy, smelly urine without symptomsNo culture; encourage fluids and observe
Culture resultE. coli over 100,000 colonies per mLRecognize as asymptomatic bacteriuria
Treatment decisionCiprofloxacin for 7 daysNo antibiotic
Antibiotic choice if infection were presentFluoroquinoloneA narrower agent based on culture and local resistance
Diarrhea after antibioticsTested and diagnosed C. difficileAppropriate; start guideline therapy and contact precautions
What this page is doingThe table shows that the error occurred early and that later steps were appropriate responses to a preventable problem. It gives the facility a clear picture of where to intervene.
4

Treating the New Infection

For an initial episode of C. difficile infection in adults, guidelines recommend oral vancomycin or fidaxomicin, both of which act within the gut, over metronidazole (McDonald et al., 2018). Mrs. Bianchi's elevated white cell count suggests a more significant episode, so she needs close monitoring of fluids, kidney function and signs of severe colitis. Any unnecessary antibiotics and acid-suppressing drugs should be reviewed. The facility should place her on contact precautions, have staff wash with soap and water, since alcohol rubs leave spores alive, and clean her room with a sporicidal agent.

Resistance: The Wider Cost

Beyond the harm to Mrs. Bianchi, unnecessary antibiotics contribute to resistance. Each course exposes the bacteria in the gut and urine to selection pressure, favoring organisms that survive the drug. In nursing homes, where residents share staff and spaces, resistant organisms can spread from one resident to another. Treating asymptomatic bacteriuria therefore harms not only the resident who receives the drug but also the facility's future ability to treat real infections. This is why antimicrobial stewardship programs focus heavily on urine cultures and urinary antibiotic use in long-term care.

Stewardship Changes

The facility can prevent a repeat through three changes. First, adopt clear criteria for ordering urine cultures and starting antibiotics. Consensus minimum criteria for residents of long-term care facilities without a urinary catheter call for either acute pain on urination or fever accompanied by a new or worsening urinary sign, such as urgency, frequency, suprapubic pain, visible blood in the urine, flank tenderness or new incontinence (Loeb et al., 2001). Mrs. Bianchi met none of these. Staff should be taught that cloudy or smelly urine alone is not a reason to test, and a simple checklist at the nurses' station can make the criteria easy to apply at night and on weekends, when most cultures are ordered by phone. Second, require the prescriber to document the symptoms that justify any antibiotic for a urinary diagnosis. Third, review antibiotic prescriptions weekly with the consultant pharmacist and report the facility's rates of urine cultures, urinary antibiotics and C. difficile cases to staff each quarter. These steps directly target the decision point identified in this case.

Conclusion

Mrs. Bianchi's C. difficile infection began with a urine culture ordered for cloudy urine and a positive result treated as infection. Understanding the immune difference between colonization and infection, the mechanism of ciprofloxacin and the way antibiotics disrupt the gut explains the chain of harm. National guidelines would have stopped it at the first step, and simple stewardship practices can help the facility stop it next time.

References

Loeb, M., Bentley, D. W., Bradley, S., Crossley, K., Garibaldi, R., Gantz, N., McGeer, A., Muder, R. R., Mylotte, J., Nicolle, L. E., Nurse, B., Paton, S., Simor, A. E., Smith, P., & Strausbaugh, L. (2001). Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: Results of a consensus conference. Infection Control & Hospital Epidemiology, 22(2), 120-124. https://doi.org/10.1086/501875

McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., Loo, V., Shaklee Sammons, J., Sandora, T. J., & Wilcox, M. H. (2018). Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clinical Infectious Diseases, 66(7), e1-e48. https://doi.org/10.1093/cid/cix1085

Nicolle, L. E., Gupta, K., Bradley, S. F., Colgan, R., DeMuri, G. P., Drekonja, D., Eckert, L. O., Geerlings, S. E., Koves, B., Hooton, T. M., Juthani-Mehta, M., Knight, S. L., Saint, S., Schaeffer, A. J., Trautner, B., Wullt, B., & Siemieniuk, R. (2019). Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 68(10), e83-e110. https://doi.org/10.1093/cid/ciy1121

How this IHP 310 Module 6 example is structured

The paper tracks a chain of events, so it follows the chain. It opens with the case. The next section explains the difference between bacteria living in the bladder and a urinary infection, which is the point where the chain could have been broken. The mechanism of ciprofloxacin and the way antibiotics open the door to C. difficile come next. A table compares what happened with what guidelines recommend at each step. The paper ends with the treatment of the new infection and stewardship changes a facility can make.

Get IHP 310 Module 6 written to your instructions

Upload your IHP 310 Module 6 assignment, the rubric and the case you are analyzing. An infection and antimicrobial analysis written to that case returns within 24 to 48 hours, and the first is free. The paper above is an original model document written by our desk, not a submitted student paper and not an official Southern New Hampshire University document.

IHP 310 Module 6 questions, answered

What does IHP 310 Module 6 usually cover?

Around this module, pathophysiology and pharmacology courses often address the immune system and infectious disease, including how the body responds to pathogens, antimicrobial drug classes and their mechanisms, and antimicrobial resistance. Assignments may ask for a case analysis linking these topics.

What is asymptomatic bacteriuria?

It is the presence of bacteria in the urine of a person who has no symptoms of urinary tract infection. It is very common in older adults, especially in nursing homes, and in most groups it does not need treatment, because treating it does not improve outcomes and increases antibiotic harms and resistance.

Why do antibiotics lead to C. difficile infection?

Antibiotics kill many of the normal bacteria in the colon that keep Clostridioides difficile in check. With less competition, C. difficile spores can germinate, multiply and release toxins that damage the colon, causing diarrhea and sometimes severe colitis. Some antibiotic classes, including fluoroquinolones, carry a particularly high risk.